Arqt stock forecast.
ARQT has an Altman Z-Score of -5.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Arcutis Biotherapeutics, Inc. (ARQT) stock, including valuation metrics, financial numbers, share information and more.
Find the latest Arqit Quantum Inc. (ARQQ) stock quote, history, news and other vital information to help you with your stock trading and investing.Arcutis Biotherapeutics last posted its earnings data on November 3rd, 2023. The reported ($0.73) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.90) by $0.17. The firm earned $38.11 million during the quarter, compared to the consensus estimate of $9.54 million. Arcutis Biotherapeutics has generated ($4. ...On Friday, Arcutis Biotherapeutics Inc [NASDAQ:ARQT] saw its stock jump 4.62% to $2.04. On the same session, the stock had its day’s lowest price of $2.00, but rose to a high of $2.14. Over the last five days, the stock has gained 7.09%. Arcutis Biotherapeutics Inc shares have fallen nearly -86.22% since the year began.The Arcutis Biotherapeutics stock forecast for tomorrow is $ 1.868814, which would represent a 1.57% gain compared to the current price. In the next week, the price of ARQT is expected to decrease by -1.89% and hit $ 1.805195. As far as the long-term Arcutis Biotherapeutics stock forecast is ...
beststocks.com18.04 -87.30% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. Health Technology News Chart Latest ARQT News | Press Releases After Plunging -35.64% in 4...Within the last quarter, Arcutis Biotherapeutics (NASDAQ:ARQT) has observed the following analyst ratings: In the last 3 months, 7 analysts have offered 12-month price targets for Arcutis ...
Introduction. This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at …
According to 8 stock analysts, the average 12-month stock price forecast for ARQT stock stock is $33.38, which predicts an increase of 1,268.03%. The lowest target is $4.00 and the highest is $50. On average, analysts rate ARQT stock stock as a strong buy. Analyst Consensus: Strong Buy Analyst Ratings13 brokerages have issued twelve-month price targets for Royal Bank of Canada's stock. Their RY share price targets range from C$122.00 to C$142.00. On average, they predict the company's share price to reach C$133.21 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.17 equities research analysts have issued 12 month price targets for Pfizer's stock. Their PFE share price targets range from $33.00 to $75.00. On average, they predict the company's share price to reach $42.50 in the …Find real-time EA - Electronic Arts Inc stock quotes, company profile, news and forecasts from CNN Business.
The average Ocuphire Pharma stock price prediction forecasts a potential upside of 585.19% from the current OCUP share price of $2.70. What is OCUP's forecast return on equity (ROE) for 2023-2026? (NASDAQ: OCUP) forecast ROE is …
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a Westlake Village, California based early commercial-stage biopharmaceutical concern focused on the development of dermatological treatments in ...
Find the latest Capricor Therapeutics, Inc. (CAPR) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...It also enacted a public offering of common stock in 2022 where it raised $161.6 million in aggregate net proceeds. Along with the sales of stock under an ATM Facility agreement in March of 2022 ...A popular and widely used statistical method for time series forecasting is the ARIMA model. It is one of the most popular models to predict linear time series data. This model has been used extensively in the field of finance and economics as it is known to be robust, efficient, and has a strong potential for short-term share market prediction.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Arqit Quantum Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median ... Analyst projections state that ARQT is forecast to be at a low of $4.00 and a high of $50.00. In order for the stock price to hit the forecast high, the stock would need to plunge -1949.18% from its current level, while the stock would need to crash -63.93% from its current level to reach the projected low.
Nov 24, 2023 · A high-level overview of Arcutis Biotherapeutics, Inc. (ARQT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Shell PLC (SHEL:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates.Find the latest Mirum Pharmaceuticals, Inc. (MIRM) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Arcturus Therapeutics Holdings Inc have a median target of 51.00, with a high estimate of 140.00 and a low estimate of 18.00.Nov 10, 2023 · Future criteria checks 2/6. Arcutis Biotherapeutics is forecast to grow earnings and revenue by 42.6% and 50.2% per annum respectively. EPS is expected to grow by 52.7% per annum. Return on equity is forecast to be -1340.1% in 3 years. About the Arcutis Biotherapeutics Inc stock forecast. As of 2023 November 09, Thursday current price of ARQT stock is 2.200$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Arcutis Biotherapeutics stock price has been showing a declining tendency so we believe that similar market segments …
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a Westlake Village, California based early commercial-stage biopharmaceutical concern focused on the development of dermatological treatments in ...
Nov 28, 2023 · Stock Price Forecast. According to 8 stock analysts, the average 12-month stock price forecast for ARQT stock stock is $33.38, which predicts an increase of 1,268.03%. The lowest target is $4.00 and the highest is $50. On average, analysts rate ARQT stock stock as a strong buy. On Friday, Arcutis Biotherapeutics Inc [NASDAQ:ARQT] saw its stock jump 4.62% to $2.04. On the same session, the stock had its day’s lowest price of $2.00, but rose to a high of $2.14. Over the last five days, the stock has gained 7.09%. Arcutis Biotherapeutics Inc shares have fallen nearly -86.22% since the year began.Arcutis Biotherapeutics, Inc. WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (“Arcutis”) (Nasdaq: ARQT), an early commercial-stage biopharmaceutical ...Nov 2, 2023 · After registering a 0.44% upside in the last session, Arcutis Biotherapeutics Inc (ARQT) has traded red over the past five days. The stock hit a weekly high of 2.46 this Wednesday, 11/01/23, jumping 0.44% in its intraday price action. The 5-day price performance for the stock is -5.04%, and -50.55% over 30 days. UiPath’s stock soars after profit, revenue and ARR rise above forecasts Nov. 30, 2023 at 4:46 p.m. ET by Tomi Kilgore UiPath Shares Jump 13% on Surging 3Q RevenueShell PLC (SHEL:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates.Arcutis Biotherapeutics (ARQT) stock price prediction is 1.0118522608668 USD. The Arcutis Biotherapeutics stock forecast is 1.0118522608668 USD for 2024 November 09, Saturday with technical analysis.
The average Ocuphire Pharma stock price prediction forecasts a potential upside of 585.19% from the current OCUP share price of $2.70. What is OCUP's forecast return on equity (ROE) for 2023-2026? (NASDAQ: OCUP) forecast ROE is …
The average one-year price target for ARQT / Arcutis Biotherapeutics Inc is $11.39. The forecasts range from a low of $4.04 to a high of $21. A stock’s price target is the price at …
Business News - Latest Headlines on CNN Business - CNNAmazon Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.The average twelve-month price prediction for Arcutis Biotherapeutics is $33.78 with a high price target of $57.00 and a low price target of $6.00. Learn more on ARQT's analyst …The consensus price target of analysts on Wall Street is $36.63, which implies an increase of 91.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.00 and $57.00 respectively. As a result, ARQT is trading at a discount of -1781.19% off the target high and -98.02% off the low.Forecasting is the use of historic data to determine the direction of future trends. Businesses utilize forecasting to determine how to allocate their budgets or plan for anticipated expenses for ...The average one-year price target for ARQT / Arcutis Biotherapeutics Inc is $11.39. The forecasts range from a low of $4.04 to a high of $21. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to ...13 нояб. 2023 г. ... ARQT has risen $0.21 from the previous closing price of $1.91 on volume of 1,059,755 shares. Over the past year the S&P 500 is higher by 11.57% ...Stock Price Forecast. According to 38 stock analysts, the average 12-month stock price forecast for Microsoft stock is $392, which predicts an increase of 3.45%. The lowest target is $263 and the highest is $475. On average, analysts rate Microsoft stock as a strong buy.
Their ORCL share price targets range from $93.00 to $150.00. On average, they anticipate the company's share price to reach $124.23 in the next year. This suggests a possible upside of 6.9% from the stock's current price. View analysts price targets for ORCL or view top-rated stocks among Wall Street analysts.Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Arcutis Biotherapeutics Inc have a median target of 10.00, with a high estimate of 44.00 and a low estimate of 4.00. The ... Amazon Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.As of September 1, 2023, Arcutis Biotherapeutics Inc’s stock price is $8.96, which is up 4.92% from its previous closing price. At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and ...Instagram:https://instagram. best socially responsible fundsbest health insurance in montanatexas roadhouse inc stockgetty auction In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ... 1964 kennedy silver half dollar valueinside vegas sphere Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat... movers insurance ARQT is a Buy, but only suitable for long-term investors. Key risks include slow launch out of the gate, intense competition in certain areas (including from generic steroids) and dilution ...13 brokerages have issued twelve-month price targets for Royal Bank of Canada's stock. Their RY share price targets range from C$122.00 to C$142.00. On average, they predict the company's share price to reach C$133.21 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.